Johnson & Johnson receives FDA authorization for Ottava surgical robot
Johnson & Johnson received FDA approval for its Ottava surgical robot, entering the U.S. robotic soft-tissue surgery market dominated by Intuitive Surgical and Medtronic. This development could intensify competition in a growing sector.
Topics: medical_devices robotic_surgery